Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Mitchel L. Zoler, PhD

Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler

News

Catheter cryoablation effective for persistent AFib in pivotal trial

Author:
Mitchel L. Zoler, PhD
Publish date: January 25, 2020

NATIONAL HARBOR, MD. – Cryoballoon becomes the first catheter ablating device to show efficacy and safety for persistent AFib in an FDA-approved...

  • Read More

News

AFib link with titin mutations warrants selected genetic testing

Author:
Mitchel L. Zoler, PhD
Publish date: January 24, 2020

Evidence strongly links loss-of-function mutations in the titin gene with AFib, and patients are now seeking genetic testing.

  • Read More

News

Carbs, fat, and mortality: Types matter more than levels

Author:
Mitchel L. Zoler, PhD
Publish date: January 22, 2020

Low-carb or -fat diets mean less for survival than food types. Eating unrefined carbs and unsaturated fats...

  • Read More

News

FDA advisers set high bar for new opioids

Author:
Mitchel L. Zoler, PhD
Publish date: January 21, 2020

Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.

  • Read More

News

Coronary function testing during angiography boosts 1-year angina outcomes

Author:
Mitchel L. Zoler, PhD
Publish date: January 15, 2020

PHILADELPHIA – Diagnosing coronary microvascular disease or vasospasm during angiography improved angina outcomes; new findings help show why.

  • Read More

News

FDA committee rejects oxycodegol, new opioid designed for less abuse

Author:
Mitchel L. Zoler, PhD
Publish date: January 14, 2020

A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.

  • Read More

News

Half of SLE patients have incident neuropsychiatric events

Author:
Mitchel L. Zoler, PhD
Publish date: January 14, 2020

Average 8-year follow-up of an international lupus inception cohort showed that 52% developed a neuropsychiatric event.

  • Read More

News

Diabetes boosts bariatric surgery complications

Author:
Mitchel L. Zoler, PhD
Publish date: January 10, 2020

LAS VEGAS – In addition, patients with insulin-dependent diabetes had significantly higher rates of these and other complications, compared with...

  • Read More

News

HRS urges consumers to direct questions about wearables’ data to clinicians

Author:
Mitchel L. Zoler, PhD
Publish date: January 9, 2020

The Heart Rhythm Society teamed with a consumer group to release public guidance on how to use cardiac data from...

  • Read More

News

Evidence builds for bariatric surgery’s role in cancer prevention

Author:
Mitchel L. Zoler, PhD
Publish date: January 9, 2020

LAS VEGAS – Some patients are trying to reduce their future risk for cancer with the procedure.

  • Read More

News

Bariatric surgery candidates show high prevalence of thrombophilia

Author:
Mitchel L. Zoler, PhD
Publish date: January 8, 2020

LAS VEGAS – Thrombophilia screening of 1,075 bariatric-surgery candidates identified 52% as positive, which...

  • Read More

News

Score predicts bariatric surgery’s benefits for obesity, type 2 diabetes

Author:
Mitchel L. Zoler, PhD
Publish date: January 8, 2020

LAS VEGAS – The calculator can estimate the 10-year risk for death and cardiovascular disease events for patients if their clinical status...

  • Read More

News

ODYSSEY Outcomes: Alirocumab cut stroke, PAD, VTE

Author:
Mitchel L. Zoler, PhD
Publish date: January 7, 2020

PHILADELPHIA – Prespecified outcomes from the alirocumab outcomes trial showed the drug significantly cut PAD and VTE events, as well as ischemic...

  • Read More

News

New hypertension performance measures boost 130/80 mm Hg target

Author:
Mitchel L. Zoler, PhD
Publish date: January 6, 2020

PHILADELPHIA – Hypertension performance and quality measures from the AHA and ACC provide a guide for implementing the 2017 hypertension guideline...

  • Read More

News

Nearly 25% of U.S. adults take an obesogenic prescription drug

Author:
Mitchel L. Zoler, PhD
Publish date: January 3, 2020

The 2013-2016 analysis also showed a strong link between obesogenic drug use and increasing obesity severity.

  • Read More

Pages

  • « first
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close